NCQA reports HMO quality improvement
November 1st 2000According to the Washington-based National Committee for Quality Assurance's fourth annual State of Managed Care Quality report – an assessment of the industry's performance and the impact improvements will have on Americans' health – health maintenance organizations made their largest gains ever in 1999 in every region of the country and across every single clinical quality measure NCQA examines. The report, which is based on an analysis of health plan performance data from Quality Compass 2000, NCQA's database of managed care information, looks at data submitted by 466 health plans that cover some 51 million people. It also examines Americans' perceptions of managed care.
Debate over reimportation continues
November 1st 2000According to the Pharmaceutical Research and Manufacturers of America, Washington, eleven former Food and Drug Administration commissioners - who have served presidents from Lyndon Johnson to Bill Clinton - have written to members of Congress that the reimportation of prescription drugs poses grave risks for American patients. Currently, there is legislation pending before a House and Senate conference committee that would allow the reimportation of pharmaceuticals from countries where they are sold at lower prices into the United States.
AMCP releases 'sound' formulary principles
November 1st 2000The Association of Managed Care Pharmacy, Alexandria, VA, has released the "Principles of a Sound Formulary," a set of guidelines the association hopes will be used by formulary decision-makers to "balance the healthcare quality and cost equation."
Bush releases $158 billion Medicare proposal
November 1st 2000Texas Governor George W. Bush proposed state assistance programs to immediately provide prescription drugs to low-income seniors, in addition to long-term reforms to modernize Medicare. To pay for the plans, Governor Bush has set aside $48 billion in funding for state assistance programs and $110 billion in funding for Medicare modernization.
Rep finds ways to get personal
November 1st 2000For John Lumley, who is in his 11th year as a sales rep in Johnstown, PA, for Janssen Pharmaceutica, working in a small town is challenging, but lends a valuable perspective on the personal aspects of selling. Without access to the events and programs available in metropolitan areas, he has learned to watch for unique opportunities to make contact with his physicians and take the time to get to know them as individuals.
Promotional meetings, events on the rise
November 1st 2000The number of pharmaceutical company-sponsored physician meetings and events skyrocketed from 70,000 in 1993 to 280,000 in 1999, according to Newtown, PA-based Scott-Levin's Physician Meeting & Event Audit. Between 1998 and 1999, the number of events held for doctors jumped 25%.
Connecticut attorney general sues HMOs
November 1st 2000Connecticut Attorney General Richard Blumenthal announced that he has filed a class action lawsuit in the U.S. District Court in Connecticut against four of Connecticut's largest managed care companies: Anthem Blue Cross and Blue Shield of Connecticut (and its parent, Anthem Health Plans Inc.), CIGNA HealthCare of Connecticut (and its parent, CIGNA Health Plans Inc.), Oxford Health Plans of Connecticut Inc. (and its parent, Oxford Health Plans Inc.) and Physicians' Health Services of Connecticut (and its parent, Foundation Health Systems Inc.).
Roche and Decode Genetics map Alzheimer's gene
November 1st 2000Decode Genetics, Reykjavik, Iceland, and Basel, Switzerland-based F. Hoffmann-La Roche Ltd. announced that scientists at Decode have successfully mapped a novel gene that contributes to the occurrence of the common form of Alzheimer's disease.
Vaccine approval process criticized
November 1st 2000A recently published House Government Reform Committee staff report criticized the Food and Drug Administration and the Centers for Disease Control for routinely allowing scientists with conflicts of interest to serve on two influential advisory committees that make recommendations on vaccine policy.
Government expands women's health research
October 1st 2000In an effort to stimulate women's health research across a variety of disciplines, the National Institutes of Health announced that it will fund 11 awards to support development of new research in women's health. The program, Building Interdisciplinary Research Careers in Women's Health, seeks to increase the number of researchers working on women's health issues and to mentor junior researchers in an interdisciplinary scientific setting by pairing them with senior investigators.
Lilly's Prozac patent ruled invalid
October 1st 2000The U.S. Court of Appeals, Federal Circuit in Washington, D.C., has ruled in favor of Pomona, NY-based Barr Laboratories Inc.'s double patenting claim against the patents protecting Indianapolis-based Eli Lilly and Co.'s Prozac® (fluoxetine HCl) anti-depressant. The decision strikes down the patent that would have expired in December 2003; however, the Court of Appeals affirmed the decision of the lower court with respect to the expiration of the patent in February 2001.
Seniors' prescription drug costs projected to rise
October 1st 2000According to a new report by Washington-based Families USA, senior citizens can expect their drug prices to more than double in the next 10 years. The report is based on figures from the Medicare Current Beneficiary Survey, a household survey of about 12,000 elderly and disabled Medicare users.
NIHCM Foundation questions patent laws
October 1st 2000Federal intellectual property protection laws have significantly delayed the entry of some generic drugs into the U.S. market, forcing consumers to incur billions of dollars in prescription drug costs that they otherwise might not have paid, according to an analysis released by the Washington-based National Institute for Health Care Management Foundation.
Arthritis linked to weak immune system
October 1st 2000According to a study published in the Proceedings of the National Academy of Sciences (vol. 97, no. 16), researchers at the Rochester, MN-based Mayo Clinic have identified premature aging in the immune systems of patients with rheumatoid arthritis. This finding reverses the earlier belief that these patients have overactive immune systems.